Meadow Biosciences Launches First National Telehealth Platform Dedicated To Leucovorin Care For Children With Autism
Physician-founded platform brings clinician-guided leucovorin access to families in all 50 states as autism rates reach historic highs and medication waitlists stretch to two years NEW YORK, April 14, 2026 /PRNewswire/ -- Today, Meadow Biosciences launches a physician-led telehealth...
View original →